Future studies on the interplays among HMGA1, PDX-1, and MafA might be useful in understanding the molecular basis of clinical phenotypes in certain clinical conditions where insulin secretion becomes compromised (i.e., diabetes mellitus and other categories of glucose intolerance). This evidence concerns the gene MAFA and diabetes mellitus.